Lv4
598 积分 2023-09-05 加入
TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice
1个月前
已完结
Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction
2个月前
已完结
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
3个月前
已完结
Interpretable Radiomics Model Predicts Nanomedicine Tumor Accumulation Using Routine Medical Imaging
6个月前
已完结
皖公网安备34019202002308
